Clinical Trial Update: Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed first-line therapy combining bortezomib, chemotherapy, and rituximab in patients with stage III or IV follicular lymphoma. Results from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Velcade (bortezomib)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED